This comment to @margbrennan on @FaceTheNation
makes a lot more sense after learning in the VRBPAC materials posted today that Moderna submitted data on children <6 on *April 18th* — close to 2 months ago. This means regulatory delays were even longer than we realized. 1/🧵

https://twitter.com/sophiacbess/status/1525448127288856576

In the executive summary, we learn that Moderna submitted data at different times for different age groups. Here are the dates:
🗓️6m-5: April 18, 2022
🗓️6-11: March 8, 2022, w/updates May 4, 2022
🗓️12-17: June 9, 2021, w/updates May 9, 2022
fda.gov/media/159189/d…

Excellent piece from @CarolineYLChen out today in
@propublica on rising risks for children under 5. A parent asks, "[Can] advisory boards look me in the eye and say, ‘Your son is better off getting COVID without the vaccine than with some protection?’” 🧵propublica.org/article/whats-… @CarolineYLChen @propublica Experts @GovindPersad, @BurgartBioethix & @emily_a_largent asked a similar q: "Regulators should have focused on one question: Is a young child safer being vaccinated against the coronavirus now than waiting unprotected for two months?" washingtonpost.com/opinions/2022/…

@AmerAcadPeds, many changes since your 2021 statement opposing off-label vax:☑️Favorable safety & eff. data for 5-11; 0-2 trial success☑️Indirect protection from vaccinated reduced w/Omi☑️<5 EUA delayed☑️Rising <5 hospitalizations & more. Will you provide an update? #offlabelu5 @AmerAcadPeds Sources: 1. August statement from AAP aap.org/en/news-room/n…

Today, on #KidsVaccinesDay, I want to talk about an off-label *option* to vaccinate children < 5. Is that getting ahead of the science, you ask? No! The science and the ethics align in support of #offlabelU5. Read on… 🧵1/n First, let’s talk about how we got here. What happened with Pfizer’s pediatric trial? @dr_kkjetelina did an excellent explainer on this topic. Bottom line: 3 mcg worked in kids 6m – 2 years, but the dose was too low for 2-5s. yourlocalepidemiologist.substack.com/p/why-did-the-…